About this trial
As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered.
Patients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18-85,
Patients scheduled for intensive care for at least 15 days due to SAH, unruptured intracranial aneurysm, and/or Arterovenous Malformation,
Those with a Mini Mental State Examination score of > 24,
Those with a Glasgow Coma Score of 15,
Disqualifiers
Patients whose GCS fell to 14 or below for any reason during the study period;
Patients who developed septic shock and MODS;
Patients requiring endotrachial intubation and mechanical ventilation due to ARDS;
Those requiring vasopressors such as NE at a rate of >0.25 mcg/kg/min;
Trial design
Parallel
Treatments tested in this trial
Routine Therapy (Medical, environmental accodamation, face-to-face commucation)
Other interventionIn the treatment of delirium, a treatment program will be implemented in line with the recommendations of international guidelines.
Biopsychosocial-Based Multimodal Approach
Procedure/SurgeryDelirium treatment will be implemented in accordance with international guidelines. Additionally, a basic body awareness therapy and communication program will be implemented.
Treatment groups
Trial outcomes
Primary outcomes
Charlson Comorbidity Index
Charlson Comorbidity Index
Charlson Comorbidity Index
Mini-Mental State Examination Test
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Emre Şenocak
Lead sponsor
Karadeniz Technical University
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: